Cefaclor: Into the Next DecadePeter Cole (FRCP.) |
Contents
List of Contributors | 1 |
a German experience with 9472 patients | 15 |
Discussion | 30 |
Copyright | |
3 other sections not shown
Common terms and phrases
acid activity acute addition adults adverse drug adverse events amoxycillin ampicillin anaerobic antibiotic antibiotic-associated Antimicrob Agents Chemother antimicrobial appears associated bacterial beta-lactamase bronchial bronchitis catarrhalis cause cefaclor cephalexin changes chronic Clin clinical Clostridium Cole colonization common comparative comparison considered courses cultures daily diarrhoea difficile disease drug drug reactions effect efficacy evaluation example faecal flora frequently gastrointestinal Haemophilus influenzae higher hospital important incidence increase indications intestinal involved isolates Italy Laboratory less levels lower mechanism medication Microbiol observed oral cephalosporin organisms otitis media particular pathogens patients Pediatr penicillin pneumoniae positive possible present produce pseudomembranous colitis reactions received recent reference relatively reported resistance respiratory tract response severe showed sinusitis species sputum Standards stool strains suppl symptoms Table therapy toxin treated treatment upper urinary tract infections vancomycin vitro Wilson